1 documents found
Information × Registration Number 0225U002794, (0123U101344) , R & D reports Title Improving the Prevention and Treatment of Multidrug-Resistant Tuberculosis in the COVID-19 Pandemic popup.stage_title Персоніфікувати лікування, удосконалити діагностику та профілактику МЛС-ТБ в умовах пандемії COVID-19 та військового стану. Head Todoriko Liliia D., д.мед.н. Registration Date 04-04-2025 Organization Bukovinian State Medical University popup.description1 Improving the prevention and treatment of MDR-TB in the conditions of the COVID-19 pandemic and wartime period popup.description2  Personalizing etiotropic treatment and enhancing the pathogenetic treatment program during the intensive phase of chemotherapy for patients with multidrug-resistant tuberculosis reduces the length of hospital stays (to about 1 to 1.5 months), improves patients' quality of life, and helps to combat stigma. Developing and implementing a prevention algorithm for personalized treatment of multidrug-resistant tuberculosis during the COVID-19 pandemic and under military conditions decreases the spread of tuberculosis infection, particularly among conscripts and internally displaced persons. Product Description popup.authors Yeremenchuk Inha V. Pidverbetska Оlena V. Todoriko Liliia D. popup.nrat_date 2025-04-04 Close
R & D report
Head: Todoriko Liliia D.. Improving the Prevention and Treatment of Multidrug-Resistant Tuberculosis in the COVID-19 Pandemic. (popup.stage: Персоніфікувати лікування, удосконалити діагностику та профілактику МЛС-ТБ в умовах пандемії COVID-19 та військового стану.). Bukovinian State Medical University. № 0225U002794
1 documents found

Updated: 2026-03-27